Atlas FDA

COLOGUARD

FDA premarket approval P130017/S005 · decided 2015-12-23

Approval details

PMA number
P130017
Supplement
S005
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
COLOGUARD
Generic name
System, colorectal neoplasia, DNA methylation and hemoglobin detection
Applicant
Exact Sciences Corporation
Date received
2015-12-04
Decision date
2015-12-23
Days to decision
19 days
Decision code
OK30
Product code
PHP
Advisory committee
Pathology
Expedited review
No
Location
Medison, WI
Statement
CHANGE THE FOLLOWING: USE OF SOFTWARE SPREADSHEET WORKBOOK FOR AUTOMATED DATA PROCESSING IN PLACE OF MANUAL CALCULATIONS OF ACCEPTANCE CRITERIA FOR QUALITYCONTROL (QC) TEST; REVISION OF THE UPPER SPECIFICATION LIMIT FOR QC BLANK POSITIVITY FOR MARKERSBTACT AND ACT; RELOCATION OF THE QC LABORATORIES FROM THE FIRST FLOOR TO THE SECOND FLOORWITHIN THE SAME FACILITY; AND RELOCATION OF THE LABELING AND DISPENSING ACTIVITIES INTO OTHER ROOMSON THE SAME FLOOR.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.